microbeams. This technique administers spatially-restricted peak doses of many hundreds of Grays indiscriminately to healthy and tumor tissues alike, and was proven to selectively disrupt tumor tissues, while being well tolerated by healthy ones 3 . Its success in tumor treatment has been attributed to differences in tissue radio-resistance 4 and a diminished reorganization and repair capability of tumor vessel networks with respect to healthy ones 5, 6 . The reported efficacy of MRT, though, remains a complex and partly-unanswered question, and neuroimaging methodologies able to perform rigorous follow-ups of this pre-clinical technique's effects would be of paramount importance to gain a better understanding of MRT's tissue-dependent dose response.
Modern neuroimaging is a fast-growing field, today able to provide high-quality anatomical and functional maps of the Central Nervous System (CNS) from full organs down to sub-cellular structure. MRI and CT can both attain 3D micrometric resolution via small-animal micro-MRI and micro-CT scanners. Recent in-vivo advances include ultra-high-field small animal brain imaging 7 . Brain tumor angiogenesis can also be studied via micro-MR angiography, at spatial resolutions of 60 µm and after contrast agent administration 8 . Conventional X-ray micro-CT, for its part, is able to assess the presence of tumors in small animals in-vivo 9 after contrast media injection, but otherwise affords soft-tissue sensitivity that is, in absence of contrast agents, rather low.
Ex-vivo high-resolution MRI after active staining 10 allows the study of full-organ brain tissue microstructure down to 10-25µm isotropic resolution, quantitative regional volumetric measurements, and the elaboration of several distinct image contrasts, socalled proton stains, highlighting specific anatomical features. When applied ex-vivo, these imaging methods are referred to as MR-histologies, even though they do not fully discriminate single cells. MRI-based morphologic phenotyping of neuroanatomy has been instrumental in non-destructively creating 3D full-organ atlases of a number of animal models 11, 12 , and is used for the full-organ study of neuro-pathologies and of neuro-development 13 . Moreover, by imaging local molecular water diffusion to detect microstructural differences in bio-tissues, MRI permits the calculation of 3D axonal intervoxel connectivity via diffusion tensor imaging (DTI) and fiber tractography 14 access to a unique full-organ view of (white-matter) brain organization 15, 16 . Interestingly, cutting-edge micro-MRIs, combining different kinds of MR contrasts, are able to resolve the laminar anatomy and underlying cyto-architecture of the hippocampus (e.g. using DTI and 60 microns in-plane resolution) 17 , are sensitive to brain tumor cell density 18 , detect tumor invasion 19 , recover complex 3D maps of vascular micro-architecture and can measure vascular angiogenesis 20 . Functional small-animal positron emission tomography (PET), for its part, provides dynamic images of the bio-distributions of radioactive tracers and allows a wide range of full-organ and in-vivo longitudinal followup studies for neuro-pharmacological testing and neurodegenerative disease characterization 21 . PET, though, is a relatively low-resolution imaging tool, and offers indirect-only morphological imaging.
Histology and immunohistochemistry, gold standard methodologies in neuroscience, instead, offer both sub-cellular resolution and tailored stain-dependent tissue contrasts. Still, they remain highly sample-invasive techniques (the specimen being sectioned by a microtome to produce planar histological slices), are often time consuming and mostly still lack the capability to directly render complex neuron and vessel networks developing in 3D space. The gap between histology and MRI/CTbased approaches has been filled by other powerful ultra-high resolution neuroimaging research methodologies, having varying degree of sample-invasiveness, resolution and fields of view: two-photon microscopy, for example, detects deep-brain calcium dynamics by using fluorescent indicators, reveals large-scale neuronal activity in-vivo, and renders a functional and structural image of single neurons within localized neural populations 22, 23 at the cellular and subcellular level. This method can also be combined with electrical recordings of neuronal activity 24 to obtain precious morphological and functional information simultaneously. Ex-vivo local 3D properties of single glial, astrocytic and neuronal cyto-architecture, as well as subcellular detail and synaptic organization, can also be rendered today by combining 3D light microscopic methodology with deep and uniform antibody labeling procedures 25 even after long-term sample storage. On the other hand, novel optical tissue-clearing (TC) methods enable full-organ 3D fluorescence imaging 26, 27 and the ex-vivo study of cellular and vascular M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 organization throughout entire organisms 28 . Finally, optical coherence tomography (OCT), which is an ultra-fast technique applied in-vivo, permits minimally-invasive local endoscopic optical biopsies 29 , revealing both brain 30 and tumor morphology 31 .
Furthermore, swept-source optical coherence Doppler tomography (SS-ODT), sensitive to dynamic and transient chances in 3D cerebral blood-flow, enables in-vivo functional micro-circulatory imaging of deep brain vasculature at depths down to 3.2mm 32 .
Overall, the great diversification of novel neuroimaging technology gives neuroscientists a much-expanded tool-kit with which to tackle the complexity of the CNS. Still, all these methods have evident limitations, which are more or less critical depending on the desired application: some struggle to achieve sample-coverage of more than a few millimeters (OCT, SS-ODT) or present spatial restrictions of the neuronal area of visualization (e.g. cellular visualizations are limited to the staining-area covered by calcium indicator dyes or by the antibody-label penetration depth). Others afford an only partial labelling of cell populations (fluorescence-based methodologies), or have very sample-invasive procedures (TC and deep antibody labeling, for example), which hamper any prospects of future in-vivo application. Full-organ rodent brain coverage, a non-specific both nervous-and tumor-tissue-sensitive contrast mechanism, and micrometric resolution are instead concurrent requirements to reliably study local effects in the brain of fractionated high-dose radiosurgery on both normal and cancerous neuro-morphology. X-ray Phase Contrast CT (PCI-CT) is an experimental high-resolution imaging technique of interest to biomedical research for its ability to visualize soft-matter biological tissues [33] [34] [35] [36] , providing a sensitivity 2 to 3 order of magnitudes higher than that of absorption CT 37, 38 in the hard X-ray regime. We presume that PCI-CT might be able to contribute to the study of X-ray irradiation effects on brain tissue, since the technique was reported to provide high nervous-tissue contrast complementary to MRI 39 
propagation-based phase-contrast imaging or other PCI-CT techniques, have identified blood micro-vessels 44 , the molecular layer and the granular layer in the cerebellum, and have shown how multimodal brain imaging can lead to deeper insight compared to single-technique studies 39 . Finally, PCI techniques were able to effectively localize cancer masses within the brain 40 , to demarcate tumor vs. heathy tissue boundaries 45 , to visualize cancerous tissue morphology 46, 47 and to identify cancer-driven tissue degeneration 48, 49 without addition of contrast-agent.
All of these results together show that PCI-CT is a unique ex-vivo high-resolution neuroimaging technique, providing high degrees of morphological precision, full-organ rodent brain coverage and sensitivity in the 3D visualization of both healthy and pathological CNS tissues. Moreover, PCI-CT overcomes some of the burdens and limitations of histological work-up, by allowing a dissection-free 3D virtual direct measurement of deep morphology within large samples (several cm in both width and height). Thus, PCI-CT-based high-resolution structural neuroimaging could provide new insight to ongoing oncology research on small-animals involving micrometric dosefractionation in radiotherapy. Here we investigate the possibility of visualizing the biological marks of an X-ray microbeam irradiation protocol, by evaluating rat brain PCI-CT images and comparing them to histology and MRI, with the goal of validating PCI-CT as a viable imaging technique for post-mortem MRT-treatment evaluation.
conformed to guidelines of the French Government and were approved by the ethical committee of the European Synchrotron (ESRF).
MRT irradiation:
Both radiotherapy and imaging were performed at the Biomedical Beamline ID17 of the ESRF. The first beamline hutch, stationed 42 m away from a wiggler-based synchrotron X-ray source and devoted to MRT treatment, receives filtered X-rays of wide spectral range (median energy: 90 keV; spectral range: 50-350 keV) and of high dose rates 55 (>14 kGy/s). Via a specifically engineered tungsten multi-slit collimator 56 , the beam is spatially fractionated into a comb-like dose profile, producing 25-75 µm-thick high-dose microbeams (peak doses > 100 Gy) interspersed by much wider valleys, where lower well-tolerated doses are delivered to biological samples 57 . Animals were anesthetized (4% isoflurane inhalation, for induction, and ketamine, 100 mg/kg, + xylazine, 10 mg/kg, i.p., for maintenance) and positioned on a stereotactic frame 53 . Rat brains were then irradiated with microbeams 50 µm in width and 1 cm in height, both uni-directionally and by 90 degree cross-firing 58 . Inter-microbeam spacing was varied between different sample irradiations, determining center-to-center (c-t-c) inter-microbeam distances of 200 or 400 µm. Moreover, three microbeam peak entrance doses were selected (250, 400 and 600 Gy, measured at 2 mm depth). A total 1 cm 2 square-shaped irradiation area was delivered posteriorly and laterally to the cranium bregma point. MRT valley doses for 50 µm thick microbeams with 200 µm c-t-c distance are reported 59 to scale the peak dose by a factor of ~ 1/27, leading to estimated valley doses of around 9, 15 and 22 Gy (for the MRT treatments with peak doses respectively at 250, 400 and 600 Gy). In the 400 µm c-t-c distance case, the scaling factor is reported 60 to be ~ 1/57, leading, as expected, to lower valley doses, respectively of 4, 7 and 11 Gy. Since dose scales linearly, 2-direction cross-firing irradiations lead to a doubling of the dose in the valleys. 
Sample-specific irradiation parameters:

Propagation-based Phase Contrast Imaging:
Post-mortem imaging was performed in the ID17 imaging hutch (150 m away from the source), using a standard propagation-based PCI (PBI) experimental setup [61] [62] [63] . The 9 extracted brain samples were placed in a formalin-filled Falcon tube and illuminated with highly-collimated quasi-coherent monochromatic 26 keV X-rays. A low-noise 2k CCD FReLoN camera 64 
Vessel network renderings:
Brain vessel-network segmentations were obtained using a region growing algorithm (applied to sample 9 datasets), and the 3D renderings were produced using the commercial software VG Studio MAX 67 . Moreover, brain vessel 2D maximum intensity projection maps were computed over 200 consecutive slices (from sample 2 and 4 data) by awarding to each particular pixel location its maximum value over all images in the stack (i.e. the maximum intensity z-projection function in ImageJ software (NIH, USA), a method which highlights bright 3D features and maps them onto a 2D plane).
Histology & Immunohistochemistry:
Hematoxylin/eosin (H&E) histology was performed on samples 2-9. Nissl staining, Perls' Prussian Blue staining, specific for iron deposits, and Alizarin Red S staining, specific for calcium deposits, were performed after imaging on two MRT-irradiated and tumorbearing brain samples (sample 2 and 6). Formalin-fixed brains were included in paraffin Vector Laboratories).
MRI Experiment:
One MRT-irradiated tumor-bearing brain sample (sample 1) was additionally ex-vivo imaged inside a formalin-filled Falcon tube with a pre-clinical 9.4 T MRI scanner (BioSpec 94/20 USR, Bruker). Since all PCI neuro-images in this work were taken postmortem, the specimen was also MRI-imaged ex-vivo in exactly the same sample conditions and environment as for PCI-CT, in order to obtain a comparable MRI dataset. Axial brain images were taken using the manufacture's two channel array RX/TX cryo probe (Z125365). Coronal brain images were acquired using an eight channel RX array volume coil (T20030V3) optimized for rat brain imaging in combination with a quadrature TX volume resonator (T12054V3). We acquired both T1-and T2-weighted sequences optimized for brain anatomical high-resolution imaging.
Axial MRI sequences specifications:
2D-T2 MSME: Bruker Biospin 2D-T2map-MSME sequence; echo images: 8; echo 
Results:
Imaging brain anatomy
High resolution X-ray PCI images ( Fig. 1) of an excised control rat brain sample (sample 9) showcase the achievable sensitivity to brain anatomical detail of this imaging method, which measures small differences in local tissue density and refractivity. Sagittal and molecular (mo) layers of gray matter, part of the forth ventricle system (V4) and a large section of the medulla region (MY). PCI (e), H&E histology (f) and superposition of the two techniques (g) illustrate the structure of the granular cell layer (stratum granulosum, sg) of the hippocampal Dentate Gyrus. The third ventricle (V3) is filled with low-signal formalin in PCI (e) and is empty in the histology slice (g). Fig. 2 , data from samples 1-5) was observed via PCI within brain striatum, thalamic (2a, 2e) and hypothalamic regions ( Fig. 2c-d ), as well as partly growing inside lateral ventricles ( Fig. 2a ). GBM neoplasms can be recognized as regions of higher phase-contrast relatively to surrounding normal brain parenchyma and to contralateral non-implanted brain hemispheres ( Fig. 2a , 2c-f). Core GBM lesions feature hypercellularity, comprised of a mix of densely-packed astrocytes, blood vessels and other cells, an abnormal hyper-dense cellular microenvironment, which modifies local refractive properties and densities compared to those within normal nervous tissue, thereby influences PCI signal and seems to lead to local hyper-intensity within GBMs ( Fig. 2a , 2c-f).
Imaging glioblastoma tumor
Figures 2a-b highlight PCI intensity differences within one selected tumor-bearing brain
sample: some of the lowest gray-levels pertain to the low-density formalin environment surrounding the sample and within formalin-filled ventricles and blood vessels (samples were formalin-fixed and vasculature was at least partially perfused). Normal nervous tissue presents average gray-levels slightly above those pertaining to formalin (see cortex and amygdalar gray-levels in Fig. 2a-b ). Peaks in the gray-value profile seem instead to correspond to local vasculature, which was not completely washed during perfusion: vessels partially filled with densely-packed blood cells or with collapsed endothelial membranes, create local hyper-density areas detected by the PCI technique. PCI signal within GBM tissue was found on average higher than nervous tissue in all inoculated cerebra, with signal contributions coming from all sources of hyper-density: notably the typical densely-packed cancerous cellularity and the increased and aberrant vascularization ( Fig. 2 c-e), and even localized tumor-driven M A N U S C R I P T
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blood extravasations or tissue calcification ( Fig. 2e ), all contribute to give rise respectively to the highest average gray-levels and to intra-GBM signal peaks. Other areas of low PCI signal arise from necrotic areas at the center of tumor masses, affording troughs within GBM gray-value profiles ( Fig. 2a -c, 2e): cell death causes decreased cellularity and even the formation of empty cystic cavities, which diminishes the local density and local refraction effects and affords a PCI signal similar (or even lower) to that of formalin-filled brain ventricles (see trough within the GMB gray-level profile in Fig. 2b , marked as necrotic in origin). PCI signal is admittedly non-specific in nature, in that different features can give rise to similar PCI intensity levels. Fig. 2a-b show that it is indeed difficult to differentiate formalin from an empty vessel from a cyst in a necrotic area (all hypo-intense features) based on PCI signal alone, as is difficult differentiating between filled vessels and tumor tissue (both hyper-intense features). In these cases, gray-level-based structure differentiation must be complemented by morphological observations. What is though possible with PCI, is to differentiate between low-intensity and high-intensity features, and, most importantly, to recognize these structures within normal nervous tissue. hypo-dense empty vessels correspond to dark formalin-filled tubules in PCI ( Fig. 3e vs. 3e'). H&E staining confirmed the presence of collapsed blood vessels ( Fig. 3b'') , of vessels half-filled with blood red cells (3c''), of collapsed vessel with packed red blood cells (3d''), and of empty blood vessel (3e''). The full laminin histology vs. the corresponding PCI image can be found in Suppl. Fig. 8 .
Larger superficial blood vessels with thick hyper-dense endothelial membranes, residing in the subarachnoid space, are visualized as bright tubes covering most of the external organ ( Fig. 3i ). Intra-cortical vasculature and capillaries, branching radially inwards from the outer layers toward the inner brain ( Fig. 3a, 3f -g), are visible as bright tubules, when collapsed or when filled or half-filled with red blood cells, or as dark tubules, when noncollapsed and formalin-filled. The full-organ angio-architecture, comprised of anterior (ACA), middle (MCA) and posterior cerebral arteries (PCA) can be followed on 2D MIPs both in healthy samples ( Fig. 3f-h) , where it is notably hierarchically organized and evenly distributed, and in tumor-bearing samples (Fig. 3i-k) , which, as is well-known 69 , features densely-packed immature, tortuous and disorganized tumor vasculature in and around the malignant lesions (data from sample 2, 4 and 9). Deep hyper-dense microvascularization was detected extending to the center of the organ as an organized and tidy network in a healthy brain (Fig. 3h ), or as a chaotic bundle wrapping around the M A N U S C R I P T
GBM in a tumor-bearing cerebrum (Fig. 3j ). Undeniably, it is difficult to differentiate between signals from local aberrant vessel anatomy and GBM tissue hyper-cellularity within the core of neoplasms in 2D, as both anatomical components are present at the same time: a close-reading of local 3D morphology and of relative gray-level differences is needed in this case (Fig. 3i-k) . Vasculature within healthy parenchyma, as the tumorfree vasculature imaging in Fig. 3f-h demonstrates, is instead much easier to recognize.
Further 2D and 3D PCI-based renderings of tumor and vascular anatomy can be found in Suppl. Fig. 9 . 
Imaging MRT irradiation
After imaging healthy and cancerous brain micro-morphology, we investigated PCI's ability to visualize fractionated radiation effects on nervous tissue, with results summarized in Fig. 4 (data Fig. 4a-e ) and were confirmed by comparison to histology (Fig. 4a '-e' vs. 4a''-e'').
Finally, the ablations were related to similar patterns appearing also in MRI images (Fig.   6 ).
Via PCI, different modes of irradiation can be recognized, differentiated and verified post-treatment: cross-firing modes (Fig. 4b and 4d ) feature a checkered irradiation signature, as opposed to the striated patterns typical of unidirectional treatment (Fig. 4a,   4c , 4e). Post-irradiation tumor growth and post-mortem sample preparation play a role in making the micrometric hypo-dense striations appear only quasi-parallel or even curved. Still, relative spacing in-between ablations is preserved. Radiation-driven tissue ablations are likewise detected by PCI as they target cancerous masses (Fig. 4c, 4d ).
We observe MRT beam-paths transect distorted hippocampal cell layers, hyperplastic vessels ( Fig. 4c, 4c' ), or cortical brain tissue (Fig. 4d, 4d' ) and hit implanted tumors, which are calcifying, present extravasations (Fig. 4c ), or are infiltrating adjacent regions ( Fig. 4d ). Microbeams slice the target region into parallel micro-planes, and blood vessels within nervous tissue are also traversed by the radiation. Despite the high doses delivered (> 250 Gy), we observe preservation of vascular anatomic continuity post-treatment of both large and microscopic vessels: vasculature can be followed branching across microbeam-ablated areas, resist microbeam erosion and connect to valley-dose tissue regions (Fig. 4e, 4e' ). By comparison to H&E histology, microbeams appear well resolved by PCI within the layers of denser cellularity and with abundant cell bodies, such as the cerebellar granular layer (Fig. 4a'-a'') , areas within the cortex and midbrain regions ( Fig. 4b', 4b'' ) or the packed pyramidal and granular layers of the hippocampus (Fig. 4c', 4c'' ). Less image contrast is achieved when the ablations cross the cerebellar molecular layer and white matter regions (Fig. 4a'-a'' ), or the sparser-incell-bodies and more fiber-rich hippocampal strata ( Fig. 4c', 4c'') , though a glimpse of their presence and directionality can be in most cases still recognized by the expert eye.
Signs of intra-microbeam reactive gliosis are revealed by GFAP ( Fig. 4d'' ) and compared to PCI (Fig. 4d') 
PCI-CT & Histology
PCI as an anatomical neuroimaging modality was compared to histology and to immunohistochemistry in MRT-driven ablations are also visible via all three techniques ( Fig. 5a,b,c) . Broad pathologic hyper-intense regions in PCI, attributed to GBM cancerous tissues already in Fig. 2 , are visible in the PCI coronal slice in Fig. 5a . Again, GBM hyper-intense signal and altered morphology in PCI finds histological match in the signal and morphology of the most strongly marked tissues of both Nissl and H&E histology data (Fig. 5a,a'' vs. 5b,b'' and 5c,c'): denser and altered GBM cancerous cellularity seen via histology (5b'', 5c') leads to macroscopic tumor-driven morphological tissue modifications and to cellular hyper-density, both of which increase PCI signal (5a''). Normal striatal tissue cellularity (5b'), in comparison, leads to a lower more homogeneous PCI signal (5a').
Though the cellular level reached via histology is not fully resolved in PCI at this imaging resolution, we observe once again how tissue cellular micro-milieu and macroscopic morphological differences between normal and cancerous tissues together play an important role in determining PCI signal differences.
Immunohistochemical analysis ( Fig. 5d-f ) of GFAP, a marker of reactive gliosis, Iba-1, a microgliosis marker, and Ki-67 protein, a marker of proliferating cells, shows the altered cellularity in the tumor mass detected via PCI, and additionally allows the identification of different cellular types in the tumor. Analysis of GFAP (Fig. 5d, 5d') shows the presence of reactive astrocytes within cancerous tissues, and few reactive astrocytes also along MRT microbeam paths (see MRT tissue ablations and immunohistochemistry also in Fig. 4d'-d'' ). Analysis of Iba-1 (Fig. 5e, 5e') shows the presence of a massive microglial inflammatory infiltration within cancerous tissues, and very few microglial cells along MRT microbeam paths. Finally, analysis of the expression of the Ki-67 protein ( Fig. 5f, 5f') shows the presence of dividing cells within cancerous tissues only.
Next, PCI images of MRT-treated tumor-bearing samples were often observed to present areas of bright globular agglomerates (Fig. 5g ) within and surrounding tumor tissues. Due to image windowing, these ultra-dense areas (most likely pertaining to an absorbing high-Z material) appear as extended bright saturated patches in PCI (Fig   5g' ), though they are actually grainy in morphology, as visible when gray-levels are better adjusted to visualize these features alone (Fig. 5g'') . In Fig. 5h-h' , obtained by multiplication of 5g' and the inverse of 5g'', we can create artificial intra-agglomerate M A N U S C R I P T
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image contrast, which enables the visualization of the correct agglomerate local morphology via PCI. In fact, by substituting to the original image the ultra-dense patches in Fig. 5g '', this time with inverted pixel gray-levels, we form central dark/black ultradense clusters, which highlight the proper local shape of the ultra-bright region in the original unaltered PCI image in Fig. 5g . Histological analysis characterized the ultradense PCI-detected features in Fig. 5g -h as regions of altered cellular composition (Fig.   i,i') , where accumulation of calcium (Fig. 5j,j' ) and iron deposits (Fig. 5k,k') is present. In fact, the ultra-dense agglomerates in PCI (dark pixels in Fig. 5h ) correspond to large areas of altered tissue cellularity and possible calcification in H&E histology (Fig. 5i) .
Moreover, these same areas are positive to Alizarin red S staining (Fig. 5j) , specific for calcium deposits, and to Perls' Prussian Blue staining (Fig. 5k) , specific for the detection of iron. The broad shapes of the deposits are closely matching in all four methodologies ( Fig. h-i-j-k) . Moreover, by zooming in and viewing the agglomerates at the supracellular level (Fig. h '-I'-j'-k'), we observe how the deposits are composed of many localized round grains in both PCI (Fig. 5h ', dark/black grains), H&E histology ( Fig. 5i', dark-pink grains), after Alizarin red S staining ( Fig. 5j', red grains) and after Perls' Prussian Blue staining (Fig. 5k') . Again the methods all afford similar morphological results and complement each other in terms of functional information. The presence of calcium and iron accumulation within degenerating cancerous tissues, either radiationinduced, as already reported in literature [70] [71] [72] , or from intra-tumor calcification or blood extravasation, leads to very intense bright signals in PCI. We can conclude that highly dense materials (such as iron and calcium) strongly affect PCI imaging and could be involved in the formation of the PCI signal hyper-intensities observed within vasculature (from iron-rich blood aggregates) or within GBM tissues (again from the high blood volumes likely present). These results, supported by the immunohistochemistry in Fig.   5 , are in line with the characterization of both GBM and vasculature morphology made in Fig. 2 and 3 . Full histological and immunohistochemical datasets are included in Suppl. Fig. 10 . 
PCI-CT & MRI
Various both T1-and T2-weighted ultra-high-field 9.4 T MRI measurements were performed on one brain sample (sample 1), and compared to the X-ray PCI-CT datasets. The MRI sequences, optimized for high-resolution brain anatomical imaging, were selected to serve as an additional established basis for the validation of PCI as a morphological neuroimaging technique. Selected best results are included in Figure 6 (with sequence specifications in the Methods), and a complete dataset, showing the comparison of PCI signal to 10 different MRI sequences and related sequence M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 21 specifications, can be found in Suppl. Fig. 11 (axial images) and Suppl. Fig. 12 (coronal images). As a note, the sample faced long-term storage immersed in formalin.
As previously reported in literature 73 , formalin fixation permanently alters relaxation and diffusion properties of CNS tissues, with resulting both T1 and T2 times being reduced with respect to standard fresh unfixed slices or compared to in-vivo imaging. In fact, the measured T1 and T2 maps (Suppl. Fig. 13) show reduced T1/T2 times compared to standard literature values (Suppl . Table 1 and Suppl. Table 2 ). In light of this, the MRI data presented here (Fig. 6 ), though it can still serve as an established platform for the validation of PCI neuro-contrast, it is not appropriate for a quantitative contrast comparison, which would need specific ex-vivo MRI sample fixation, washing and staining procedures 10 in order to fully exploit the technique's potential.
Full-organ gross brain anatomical features are visible in axial images from both T1weighted ( Fig. 6a ) and T2-weighted ( Fig. 6b) MRI. Furthermore, we observe that the corresponding PCI-CT dataset slice (Fig. 6c ) renders a matching sample brain local morphology, for example, in the layers of hippocampal tissue, in brain ventricles, in the striatum region and for large fiber tracts. The DTI metric D ZZ tensor symmetric component (a diffusion map) and RARE imaging ( Fig. 6d-e ) both show high fiber-tract contrast (forebrain bundles especially) compared to corresponding PCI-CT (Fig. 6f) , which instead seems more sensitive to the densely-packed micro-environment of neuron cell-bodies in the hippocampal pyramidal and granular layers. MSME (Fig. 6a) , MGE (Fig. 6g) , FLASH ( Fig. 6b ) and RARE (Fig. 6e,h) sequences all detect the microbeam-induced tissue ablations visible in PCI-CT images (Fig. 6c,f,i) . Microbeams appear as hyper-intense parallel lines in the MSME and FLASH scans, and instead as hypo-intense in both MGE and RARE maps. MRT tissue ablations feature local hypodensity, and thus appear hypo-intense in PCI maps, as already shown in Fig. 4 . Both imaging techniques well describe intra-cerebral calcifications and iron deposits (see also Fig. 5 ), which are hypo-intense in MRI and hyper-intense in PCI-CT ( Fig. 6a,b vs. 6c and 6d,e vs. 6f). Finally, overall tumor morphology can be appreciated in both imaging modalities ( Fig. 6a vs. 6c, and 6e vs. 6f ). PCI-CT's higher resolution benefits the visualization of local intra-tumor details from pathological GBM cellularity and vasculature (Fig. 6c,f) . 
Discussion:
This experimental neuroimaging study evaluates how well PCI-CT imaging can visualize the effects of MRT on normal and tumor tissue in the brain of an animal model.
Our results show micrometric histological precision and high soft-tissue contrast without addition of contrast agent ( Fig.1-4 , Suppl. Fig. 7) , enabling effective 3D full-organ segmentations and renderings of complex anatomical and pathological brain structure ( Fig. 2, Suppl. Fig. 9 ).
Being sensitive to the refraction of X-rays in matter, PCI-CT is particularly adapted to visualize weakly absorbing details, like those often encountered in biology and medicine. In fact, this imaging method has already been demonstrated to enable the ex-vivo analysis of a broad range of biological tissues, and has been recognized as interesting for biomedical applications and experimental studies 33 . Of note in the result presented in this work is the variety of concurrent anatomical detail PCI is sensitive to: intra-cortical micro-vasculature and cancerous lesions are well depicted alongside MRTdriven tissue ablations and minute cerebral structures, such as the dentate gyrus within the dorsal hippocampus or the choroid plexi within lateral ventricles ( Fig. 1-3) .
Moreover, worth mentioning, and of interest to preclinical studies, beyond a delineation of ex-vivo CNS gross anatomy comparable to that of MRI ( Fig. 6 ), is the achievable M A N U S C R I P T
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23 degree of precision in the rendering of brain and brain tumor micro-anatomy, even after sample storage in formalin fixative. For example, phase-contrast within several neuronal microscopic strata, such as the pyramidal and granular layers of the hippocampal formation, was observed both in healthy layers and after transection by MRT radiation (Fig. 1e, Fig. 4c') . Micrometric striated tissue ablations, traced by high-dose parallel Xray microbeams, forming comb-like hypo-dense patterns, were visible via PCI imaging also in cerebellar and cerebral regions of the brain organ ( Fig. 3) . Last, we observed diverse of local tissue effects due to both MRT treatment and GBM tumor growth, from pseudopalisading ( Fig. 2e ) and to necrosis (Fig. 2c,e ), to intra-tumor deposition of iron and calcium granular aggregates ( Fig. 2e, Fig. 4c, Fig. 5g -h-h') and to tumor infiltration ( Fig. 4d and 5 ).
As already mentioned, in terms of contrast mechanism, the X-ray PCI-CT technique exploits the phase effects of an X-ray wave within a material 49 , a process governed by its index of refraction. In simple terms, the technique produces a 3D spatial distribution of phase shifts, which depend on local material properties including the local electronic density. Macroscopically, this signal can be understood as a map of the local density and refraction-related properties of a material, with PCI image contrast arising from local relative differences in these properties. This fact holds true also for biological materials, such as the nervous tissue in the brain, where absorption effects are generally quite small. High PCI contrast can be observed in Fig.1 , for example, between the two (granular and molecular) layers of gray matter in the cerebellum (Fig. 1a, 1d ).
The granular layer contains a high number of small but densely-packed neuron cells (granule cells) and is reported to make up a disproportionate amount of the brain's mass compared to its volume, thus forming a peculiarly dense layer 74 . Instead, the cells present in the nearby molecular layer, are much sparser. This difference in cellular composition is well-described by H&E-stained histological cerebellar slices, where the abundant cell-bodies in the granular layer stain dark violet (hematoxylin attaches to intra-soma DNA/RNA), whereas the molecular layer, where fewer cell nuclei are present, stains mainly pink (from the eosin). Interestingly, the two layers show distinctly different PCI signals (see Fig. 1a and 1d, labeled mo and gr) and give rise to high phase-contrast. MRI contrast between granular and molecular layers, instead, is 39 to be low, suggesting that similar tissue environments for water molecules and low differences in local vasculature and blood volumes are present. Since the key tissue feature discriminating between the cerebellar gray matter layers is the difference in cellular density and composition (and thus of tissue cellularity, intended as number and type of cells present), the observed high PCI contrast within these layers points toward a link between PCI signal and local brain tissue cellularity. This connection seems to hold also in the white matter layer of the cerebellum. Central to the granular layer and formed mainly by input and output nerve-fiber systems, it is also poor in cell somas (being mainly composed of climbing and mossy fibers) and it typically stains mostly pink in H&E histology. As expected from its cellularity (low cell-soma densities), its PCI signal (see Fig. 1d , labeled arb) is also relatively hypo-intense relatively to the granular layer. Finally, the same relationship can also be seen in the granular vs. molecular layers of the hippocampus in Figures 1e-f-g: the H&E histology stains the granular layer mostly violet and the molecular layer mostly pink (Fig. 1f) , highlighting cellularity differences. And the PCI too exhibits hyper-intensity in the granular layer compared to the molecular one ( Fig. 1e ). Several other figure panels (in Fig. 2, 4 and 5) compare brain tissue cellularity highlighted by H&E staining to corresponding PCI contrast. What we observe overall is a representation of local brain morphology (how tissue shapes are visualized), which is quite similar in both techniques (PCI vs. H&E).
Moreover, histological cellular staining levels seem to relate to PCI signal intensities as well (with areas of hyper-intense PCI matching histological areas of hyper-cellularity). In light of the type of PCI contrast observed in all these tissues, a link between PCI signal and local tissue cellularity seems plausible to us. Moreover, this link seems reasonable, because for biological tissues it is their composition (and thus also their cellularity) that influences local density and refractive properties, and thus PCI measurements. which concur to generate densely-packed, blood-rich and chaotic intra-tumoral environments. This exotic tissue micro-milieu must influence local density and refraction properties, and thus should reasonably also play a role in PCI contrast formation. In panels 2f-g, 2h-i-j, and even 2e-e', we observe GBM tissues, which stain dark-violet in H&E histology. PCI shows GBM tissues, which morphologically follow the histological GBM shapes, and an overall local increase in PCI signal in all datasets acquired ( Fig.   2a and 2b ). In addition, PCI-based panels 3i-j-k showcase the rich presence of local aberrant GBM vasculature and micro-vasculature. Overall, the imaging method seems to provide cancer-tissue morphological visualizations that are related to local malignant cellularity and to malignant tissue and vasculature anatomy. And, in light of the PCI contrast mechanism already noted for normal brain layers, the observed link between PCI hyper-signal, GBM density, hyper-cellularity, high blood contents and local aberrant micro-vasculature does indeed seem reasonable. This biological interpretation of the detected PCI signal seems also supported by the immunohistochemical analysis in Fig.   3 and 5. Admittedly, though, PCI is a morphological experimental imaging modality but not a functional imaging tool, and for this reason any differentiation of brain structure based on PCI intensity information should best be complemented at least partially by the recognition of specific morphological features.
As already discussed, other cutting-edge technologies used in neuroimaging have their strengths and limits: brain micro-MRI can routinely be applied in-vivo at increasing resolution for both morphological and functional imaging, but for the highest ex-vivo resolutions needs tailored 'staining' protocols and struggles to achievable submicrometric resolution. Most other high-resolution preclinical neuroimaging techniques instead can clearly observe cellular and subcellular detail, but offer only a partial or localized (often stain-dependent) anatomical visualization, including traditional 2D imaging approaches like histology or scanning electron microscopy. To the best of our knowledge, PCI is the only imaging technique providing rodent full-organ micrometric resolution in neuroimaging and high-contrast tumor imaging without extensive samplepreparation (e.g. without injection of intra-venous contrast, mechanical alterations or dissection). For its part, a current clear limitation of PCI-CT in neuroimaging is the M A N U S C R I P T
26 difficulty arising when the method is applied in-vivo in the CNS: the negative influence of high-scattering and porous materials, such as those within the skull and vertebral bones, on the detectable X-ray phase-contrast drastically reduces the quality of intraskull and intra-vertebral nervous tissue visualizations. PCI resolution limits are related to detector, optics and X-ray source technologies, and ongoing technological efforts aim to obtain even sub-micron resolution datasets (i.e. cellular level datasets) at fields-of-view interesting for brain soft-tissue small animal studies. Other limitations for in-vivo experimental applications are due to the high doses delivered in CT mode in combination with motion-artifact reduction algorithms, and to the high current acquisition times needed by laboratory setups, where the available photon fluxes are much lower compared to those available at synchrotron sources. Ongoing new developments in both dose-reduction algorithms 36 and compact high-flux X-ray light sources 75 are aimed at mitigating these challenges. Moreover, PCI-CT today can be applied also in the laboratory with several novel advanced X-ray-tube technologies [76] [77] [78] , freeing this imaging technique from a synchrotron-only setting.
The results presented here explore a young and challenging field of application for PCI, experimental neuroimaging. Though a full biological and functional characterization in many cases will still necessitate immunohistochemical analysis, the methods used here appear well-suited for post-mortem morphological brain analyses, which need to avoid any sample dissection. In fact, complex full-organ vascular and cancerous pathologies arising from GBM tumor were visualized within an excised rodent encephalon. Moreover, the morphology of biological and physical effects on nervous tissue after brain cancer radiotherapy were also faithfully depicted. The for image interpretation of future PCI-based ex-vivo imaging studies of MRT treatment using standard irradiation parameters. Tumor radio-resistance and drug efficacy studies could also benefit from the volumetric quantifications of tissue volume modifications, which PCI can provide. Finally, and most importantly, this manuscript shows how the PCI technique can precede and guide localized histological analyses (e.g. immunohistochemistry, as shown in Fig. 5 ), and how it can be used for multimodal biomedical imaging in combination with, before or after other experimental neuroimaging methodologies (e.g. before MRI, as shown in Fig. 6 ).
Conclusions:
Our results demonstrate that PCI-CT is an experimental imaging technique viable for ex-vivo follow-up studies of X-ray radiotherapy techniques, e.g. MRT, on small animal models. In fact, PCI-CT, sensitive to soft tissue morphology and composition, provided high-contrast microscale representations of 3D full-organ rodent brain anatomy. PCI images concurrently visualized deep encephalic tumor tissues, healthy tissues, micrometric angio-structure and the effects of high-dose ionizing radiation, all within a one-shot image and without the need to dissect the sample. Moreover, PCI-CT signals were shown to match histological and immunohistochemical data, and to find a counterpart also in experimental high-field MRI. In conclusion, the deep insight into brain and cancer anatomy, which this imaging technique was able to provide ex-vivo, make it an interesting tool for neurological studies. PCI-based morphological representations of complex vascular and cancerous pathologies, and of biological effects after brain cancer radiotherapy could provide new insight, among others, to studies on local brain tumor tissue radio-resistance, or on drug efficacy in experimental models of neurodegeneration. This technique can precede and guide histological analysis, and can be used for multimodal biomedical imaging in combination with or after other experimental neuroimaging methodologies. 
Summary:
Experimental X-ray Phase Contrast micro-CT provides ex-vivo 3D representations of post-mortem brain tissue and glioblastoma tumor anatomy of high sensitivity and resolution without the need for extensive sample preparation. This imaging technique proved suitable for a follow-up study of a spatially fractionated radiotherapy technique, X-ray Microbeam Radiation Therapy. We detect 50µm-thick ablations on healthy and tumor tissue, arising from locally-delivered ultra-high-dose X-ray microbeams, as well as calcium and iron accumulation within necrotic tumor tissue.
